Evidence map›Paper›PMID 35801923›Full record

ArticleNucleic acids research2022

Phosphorylation of SAMHD1 Thr592 increases C-terminal domain dynamics, tetramer dissociation and ssDNA binding kinetics.

Benjamin Orris, Kevin W Huynh, Mark Ammirati, Seungil Han, Ben Bolaños, Jason Carmody, Matthew D Petroski, Benedikt Bosbach, David J Shields, James T Stivers

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Benjamin OrrisDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine 725 North Wolfe Street Baltimore, MD 21205, USA.ORCID 0000-0003-4961-0398
Kevin W HuynhMedicine Design, Pfizer, Groton, CT 06340, USA.
Mark AmmiratiMedicine Design, Pfizer, Groton, CT 06340, USA.
Seungil HanMedicine Design, Pfizer, Groton, CT 06340, USA.
Ben BolañosOncology Research and Development, Pfizer, San Diego, CA 92121, USA.
Jason CarmodyOncology Research and Development, Pfizer, San Diego, CA 92121, USA.
Matthew D PetroskiOncology Research and Development, Pfizer, San Diego, CA 92121, USA.
Benedikt BosbachCenters for Therapeutic Innovation (CTI), Pfizer, NY, NY 10016, USA.
David J ShieldsCenters for Therapeutic Innovation (CTI), Pfizer, NY, NY 10016, USA.
James T StiversDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine 725 North Wolfe Street Baltimore, MD 21205, USA.ORCID 0000-0003-2572-7807
Pfizer (United States) · USJohns Hopkins University · US

Funding

TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCHT32CA009110 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J., WEERARATNA, ASHANI T · 1985 to 2025
$13.1M
Uracil Damage Recognition by Uracil DNA GlyocosylaseR01GM056834 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI STIVERS, JAMES T. · 1998 to 2021
$8.3M
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune SystemR01CA233567 · NCI · JOHNS HOPKINS UNIVERSITY · PI STIVERS, JAMES T. · 2020 to 2023
$1.5M
NCI NIH HHS R01 CA233567NCI NIH HHS T32 CA009110NIGMS NIH HHS R01 GM056834
6 · The paper itself

Abstract

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 (SAMHD1) is driven into its activated tetramer form by binding of GTP activator and dNTP activators/substrates. In addition, the inactive monomeric and dimeric forms of the enzyme bind to single-stranded (ss) nucleic acids. During DNA replication SAMHD1 can be phosphorylated by CDK1 and CDK2 at its C-terminal threonine 592 (pSAMHD1), localizing the enzyme to stalled replication forks (RFs) to promote their restart. Although phosphorylation has only a small effect on the dNTPase activity and ssDNA binding affinity of SAMHD1, perturbation of the native T592 by phosphorylation decreased the thermal stability of tetrameric SAMHD1 and accelerated tetramer dissociation in the absence and presence of ssDNA (∼15-fold). In addition, we found that ssDNA binds competitively with GTP to the A1 site. A full-length SAMHD1 cryo-EM structure revealed substantial dynamics in the C-terminal domain (which contains T592), which could be modulated by phosphorylation. We propose that T592 phosphorylation increases tetramer dynamics and allows invasion of ssDNA into the A1 site and the previously characterized DNA binding surface at the dimer-dimer interface. These features are consistent with rapid and regiospecific inactivation of pSAMHD1 dNTPase at RFs or other sites of free ssDNA in cells.

Indexed as

Monomeric GTP-Binding ProteinsDNA, Single-StrandedGuanosine TriphosphateKineticsPhosphorylationSAM Domain and HD Domain-Containing Protein 1DNA, Single-StrandedGuanosine TriphosphateMonomeric GTP-Binding ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, human

Identifiers

PMID35801923
PMCPMC9303311
OpenAlexW4284962828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.